Access to Oncology Medicines

Access to Oncology Medicines (ATOM) Coalition | UICC

Join the ATOM Coalition. Be part of the UICC-led efforts to reduce suffering and deaths caused by cancer in low- and lower-middle income countries through ...

Access to Oncology Medicines (ATOM) Coalition

The Access to Oncology Medicines (ATOM) Coalition is an innovative partnership, leading global collective action to increase access to essential life-saving ...

About the ATOM Coalition | UICC

The Access to Oncology Medicines (ATOM) Coalition is a groundbreaking initiative to reduce suffering and deaths caused by cancer in low- and lower-middle ...

Barriers in access to oncology drugs — a global crisis - Nature

In this Viewpoint, we have asked six oncologists working in different countries to describe how they perceive this issue in their region and propose potential ...

Access to oncology medicines in EU and OECD countries

Ensuring equal access to the latest cancer medicines is one of the most pressing challenges facing OECD health systems today.

Access to cancer medicines deemed essential by oncologists in 82 ...

Of the 20 most frequently selected high-priority cancer medicines, 19 (95%) are currently on the WHO EML; 12 (60%) were cytotoxic agents and 13 (65%) were ...

Unification of Efforts to Improve Global Access to Cancer Therapeutics

Several independent initiatives have been undertaken to improve access to cancer medicines, and additional new initiatives are in development.

The access to oncology medicines coalition: enhanced in-country ...

The new Access to Oncology Medicines Coalition initiative to address inequities and key barriers of access to essential cancer medicines and ...

Access to Cancer Medicines and Technologies

Learn more about ESMO's studies on the accessibility and availability of anti-cancer medicines, biomolecular technologies and opioids for cancer pain ...

Ensuring Global Access to Cancer Medicines: A Generational Call to ...

A new Access to Oncology Medicines (ATOM) Coalition, using public–private partnerships, aims to bring essential cancer medicines and diagnostics ...

Addressing Challenges in Access to Oncology Medicines

The OECD Health Division would like to acknowledge the valuable contributions from the. OECD Expert Group on Pharmaceuticals and Medical Devices. Writing this ...

Accessibility and Availability of Medicines and Technologies

The availability of cancer medicines is crucial for medical oncologists to be able to treat patients according to the evidence-based ESMO Clinical Practice ...

ATOM Coalition Seeks to Ensure Equitable Cancer Care in Low

A new global health initiative, the Access to Oncology Medicines (ATOM) Coalition, may be capable of reducing the burden of suffering and death from cancer in ...

Access to and Affordability of World Health Organization Essential ...

All cancer treatment regimens were not affordable OOP and some were not covered by governments. Newer targeted drugs were not affordable to all ...

Access to Oncology Medicines in Canada: Consensus Forum for ...

Patient access to new oncology drugs in Canada is only possible after navigating multiple sequential systemic checkpoints for national regulatory approval, ...

Enhancing global access to cancer medicines - Cortes - 2020 - CA

Conclusion. Various strategies can be implemented to enhance access to cancer medicines, from reducing development costs and improving ...

2022 Medication Access Report: Oncology Edition | CoverMyMeds

The 2022 Medication Access Report: Oncology Edition uncovers medication access, affordability and adherence challenges unique to those ...

How to improve access to cancer medicines in LMICs

Poor healthcare systems are a major barrier to patients accessing life-saving cancer medicines. Public-private partnerships could ensure ...

Challenges in access to oncology medicines - OECD iLibrary

With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide – and ...

New coalition to increase access to cancer medicines in LMICs

The intentions are to increase access to oncology drugs on the WHO Model List of Essential Medicines (EML) in low-income and lower-middle-income ...